Cargando…
Targeting cytotoxic T lymphocytes for cancer immunotherapy
In light of their preeminent role in cellular immunity, there is considerable interest in targeting of cytotoxic T-lymphocytes to cancer. This review summarises the active and passive immunotherapeutic approaches under development to achieve this goal, emphasising how recent advances in tumour immun...
Autores principales: | Maher, J, Davies, E T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409863/ https://www.ncbi.nlm.nih.gov/pubmed/15266309 http://dx.doi.org/10.1038/sj.bjc.6602022 |
Ejemplares similares
-
Combined targeted therapy and immunotherapy for cancer treatment
por: Guo, Cheng-Xiang, et al.
Publicado: (2021) -
Targets of immunotherapy for hepatocellular carcinoma: An update
por: Rai, Vikrant, et al.
Publicado: (2022) -
Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy
por: Kim, Gil-Ran, et al.
Publicado: (2022) -
Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
por: Ma, Shi-Xun, et al.
Publicado: (2023) -
Immunotherapy for pancreatic cancer
por: Yoon, Jai Hoon, et al.
Publicado: (2021)